Knowledge

HKBU-led research team develops novel anti-viral targeted drug for nasopharyngeal cancer treatment

A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumours caused by the virus. It is the first...

Research/Survey, Biology, Chemistry

11 May 2020 More

New HKBU-led study unveils COVID-19 transmission patterns and safety-conscious reopening plans

With the COVID-19 pandemic resulting in lockdowns in different parts of the world, from the US to many European nations, there have been intense debates on when and how we can safely reopen the economy. New research led by HKBU computer...

Computer Science

28 Apr 2020 More